TN2009000449A1 - Use of hdac inhibitors for the treatment of melanoma - Google Patents

Use of hdac inhibitors for the treatment of melanoma

Info

Publication number
TN2009000449A1
TN2009000449A1 TNP2009000449A TN2009000449A TN2009000449A1 TN 2009000449 A1 TN2009000449 A1 TN 2009000449A1 TN P2009000449 A TNP2009000449 A TN P2009000449A TN 2009000449 A TN2009000449 A TN 2009000449A TN 2009000449 A1 TN2009000449 A1 TN 2009000449A1
Authority
TN
Tunisia
Prior art keywords
melanoma
treatment
pharmaceutically acceptable
acceptable salt
hdac inhibitor
Prior art date
Application number
TNP2009000449A
Other languages
English (en)
Inventor
Peter Wisdom Atadja
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39641895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TN2009000449(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2009000449A1 publication Critical patent/TN2009000449A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
TNP2009000449A 2007-05-11 2009-10-29 Use of hdac inhibitors for the treatment of melanoma TN2009000449A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91734507P 2007-05-11 2007-05-11
US93827207P 2007-05-16 2007-05-16
PCT/US2008/063136 WO2008141114A1 (fr) 2007-05-11 2008-05-09 Utilisation d'inhibiteurs hdac pour le traitement du mélanome

Publications (1)

Publication Number Publication Date
TN2009000449A1 true TN2009000449A1 (en) 2011-03-31

Family

ID=39641895

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2009000449A TN2009000449A1 (en) 2007-05-11 2009-10-29 Use of hdac inhibitors for the treatment of melanoma

Country Status (15)

Country Link
US (2) US20110034531A1 (fr)
EP (1) EP2155193A1 (fr)
JP (1) JP2010526830A (fr)
KR (1) KR20100016376A (fr)
CN (1) CN101677995A (fr)
AU (1) AU2008251499A1 (fr)
CA (1) CA2684114A1 (fr)
CL (1) CL2008001363A1 (fr)
IL (1) IL201439A0 (fr)
MA (1) MA31365B1 (fr)
MX (1) MX2009012179A (fr)
RU (1) RU2009145803A (fr)
TN (1) TN2009000449A1 (fr)
TW (1) TW200911231A (fr)
WO (1) WO2008141114A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020354A1 (es) * 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)

Also Published As

Publication number Publication date
IL201439A0 (en) 2010-05-31
US20110034531A1 (en) 2011-02-10
CL2008001363A1 (es) 2008-12-19
JP2010526830A (ja) 2010-08-05
MX2009012179A (es) 2009-12-01
AU2008251499A1 (en) 2008-11-20
WO2008141114A1 (fr) 2008-11-20
CN101677995A (zh) 2010-03-24
MA31365B1 (fr) 2010-05-03
TW200911231A (en) 2009-03-16
US20110288144A1 (en) 2011-11-24
KR20100016376A (ko) 2010-02-12
RU2009145803A (ru) 2011-06-20
CA2684114A1 (fr) 2008-11-20
EP2155193A1 (fr) 2010-02-24

Similar Documents

Publication Publication Date Title
EA200900613A1 (ru) Спирокетоновые ингибиторы ацетил-коа-карбоксилаз
EA201070328A1 (ru) Соединения триазолопиридина и их применение в качестве ингибиторов ask
EP2178869A4 (fr) Composés d'indole en tant qu'inhibiteurs de nécrose cellulaire
EA201170473A1 (ru) Морфинановые соединения
EA201101507A1 (ru) Способы лечения солидных опухолей
EA201290919A1 (ru) Индазольные соединения и их применение
MY162157A (en) Substituted indole mcl-1 inhibitors
SG135192A1 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
UA100116C2 (ru) Профилактика или лечение воспалительного заболевания
EA201290191A1 (ru) N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ
EA201391720A1 (ru) Замещенные диоксопиперидинилфталимидные производные
ZA200806778B (en) N-Hydroxyacrylamide compounds
MX346186B (es) Inhibidores de proteina cinasas.
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
MX2009005649A (es) Tratamiento para mieloma multiple.
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
GT200600160A (es) Tratamiento del dolor
EA201390428A1 (ru) Композиции и способы лечения легочной гипертензии
MX2014007969A (es) Hidroxiamidas de ácido cinámico como inhibidores de la histona desacetilasa 8.
ATE487720T1 (de) 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer
EA201170344A1 (ru) Азаиндольные ингибиторы iap
TW200745042A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
MX2013002649A (es) Agente terapeutico contra el dolor.
TN2009000486A1 (en) Raf inhibitors for the treatment of thyroid cancer
MY160963A (en) Sustained-release therapeutic agent for hypertension and renal dysfunction